Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks
Open Access
- 21 February 2026
- journal article
- review article
- Published by Springer Nature in Perioperative Medicine
- Vol. 15 (1)
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were initially developed for the management of type 2 diabetes, due to their role in enhancing insuliKeywords
This publication has 32 references indexed in Scilit:
- Preoperative GLP-1 agonist use is not associated with perioperative aspiration or pneumonia: an observational study using US national dataBritish Journal of Anaesthesia, 2025
- Glucagon-Like Peptide-1 agonists in perioperative medicine: to suspend or not to suspend, that is the questionBrazilian Journal of Anesthesiology (English Edition), 2024
- Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight lossAnaesthesia Reports, 2024
- Delayed Gastric Emptying with Perioperative Use of Glucagon-like Peptide-1 Receptor AgonistsThe American Journal of Medicine, 2023
- Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution!Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
- Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case reportCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
- Current practice in the perioperative management of patients with diabetes mellitus: a narrative reviewBritish Journal of Anaesthesia, 2023
- Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case reportCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
- Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopyJournal of Clinical Anesthesia, 2023
- Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapyDiabetologia, 2006